Completed Safety, Immunogenicity, Efficacy of Ad26.Mos4.HIV, MVA-BN-HIV and PGT121, PGDM1400, and VRC07-523LS in HIV-1-Infected Adults NCT04983030 Conditions Acquired Immunodeficiency Syndrome, Blood-Borne Infections, Communicable Diseases, +18 more Locations UCLA CARE (Center for AIDs Research and Education) — Los Angeles, California, United States Orlando Immunology Center — Orlando, Florida, United States Beth Israel Deaconess Medical Center — Boston, Massachusetts, United States Washington University Clinical Trials Unit — St Louis, Missouri, United States View more locations Show fewer locations Loading locations... View Trial Details
